pharma · Influenza · Celiac Disease · BRNS
Barinthus Biotherapeutics
Barinthus Biotherapeutics plc.
Barinthus Biotherapeutics clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Harwell, GB
- Founded
- 2016
- Employees
- 36
- Programs
- 9
- Drugs
- 5
- Patents
- 0
Barinthus Biotherapeutics projects
7 ClinicalTrials.gov programs sponsored by Barinthus Biotherapeutics.
Barinthus Biotherapeutics has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ChAdOx1-HBV
Barinthus Biotherapeutics plc.
Chronic Hepatitis B
1 trial -
ChAdOx1-HBV
Barinthus Biotherapeutics plc.
Hepatitis B
2 trials -
ChAdOx1-HPV
Barinthus Biotherapeutics plc.
HPV Infection
1 trial -
ChAdOx1-MVA 5T4 vaccine
Barinthus Biotherapeutics plc.
Intermediate Risk Prostate Cancer
1 trial -
ChAdOx1-PCAQ
Barinthus Biotherapeutics plc.
Prostate Cancer
1 trial -
MVA-NP+M1
Barinthus Biotherapeutics plc.
Influenza
2 trials -
Seasonal influenza vaccine
Barinthus Biotherapeutics plc.
Influenza
1 trial
Frequently asked questions
How many clinical projects does Barinthus Biotherapeutics have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.